Silymarin-solid dispersions: Characterization and influence of preparation methods on dissolution

Acta Pharmaceutica

Volumn 60, Issue 4, 2010, Pages 427-443

  Sonali, Dalwadi ^a   Tejal, Soni ^b   Vaishali, Thakkar ^b   Tejal, Gandhi ^b  

^a CHAROTAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

^b ANAND PHARMACY COLLEGE   (India)

Author keywords

Co precipitation; Dissolution parameters; HPMC; Kneading; Silymarin; solid dispersions; spray drying

Indexed keywords

SILYMARIN;

ARTICLE; DISPERSION; DRUG SOLUBILITY; DRUG STABILITY; HYDROGEN BOND; SPRAY DRYING;

EID: 78650527889     PISSN: 13300075     EISSN: 18469558     Source Type: Journal    
DOI: 10.2478/v10007-010-0038-3     Document Type: Article

References (21)

1. S. Ahmad and N. Dixit, Silymarin: a review of pharmacological aspects and bioavailability enhancement approach, Ind. J. Pharm. 39 (2007) 172-179; DOI: 10.4103/0253-7613.36534.
2. S. Abrol, T. Aman and K. O. Parkash, Comparative study of different silymarin formulations: Formulation, characterization and in vitro/in vivo evaluation, Curr. Drug Deliv. 2 (2005) 45-51; DOI: 1567-2018/05$50.00+.00
3. P. D. Nakhat, R. A. Naidu, I. B. Babla, S. Khan and P. G. Yeole, Design and evaluation of silymarin-HP-b-CD solid dispersion tablets, J. Pharm. Sci. 69 (2007) 287-289; DOI: 10.4103/0250-474X.33160.
4. J. H. Hu and F. Q. Li, Improvement of the dissolution rate of silymarin by means of solid dispersions, Chem. Pharm. Bull. 52 (2004) 972-973; DOI: 10.1248/cpb.52.972. (Pubitemid 41701874)
5. S. W. Jong, T. S. Kim, J. H. Park, and S. C. Chi, Formulation and biopharmaceutical evaluation of silymarin using SMEDDS, Arch. Pharm. Res. 30 (2007) 82-89; DOI: 10.1007/BF02977782.
6. W. Wachter and H. Zeskae, Flavanolignan Preparation and their Use for Preparation of Pharmaceuticals, U.S. Pat. 5,906,991, 25 May 1999.
7. D. Voinovich, B. Perrisuiti and L. Maggaroto, Solid state mechanochemical simultaneous activation of the constituents of the Silybum marianum phytochemical complex with crosslinked polymers, J. Pharm. Sci. 3 (2008) 1-14; DOI: 10.1002/jps.21417.
8. J. B. Dressman and L. Christian, Improving drug solubility for oral delivery using solid dispersions, Eur. J. Pharm. BioPharm. 50 (2000) 47-60; DOI: 10.1016/S0939-6411(00)00076-X. (Pubitemid 30326688)
9. Y. Rane, R. Mashru, M. Sankalia and J. Sankalia, Effect of hydrophilic swellable polymers on dissolution enhancement of carbamazepine solid dispersions studied using response surface methodology, AAPS Pharm. Sci. Tech. 8 (2007) Article 27; DOI: 10.1208/pt0802027.
10. A. Avani and M. Renuka, Formulation development of taste-masked rapidly dissolving films of cetirizine hydrochloride, Pharm. Tech. 33 (2009) 48-56.
11. S. J. Hwang, D. H. Won, M. S. Kim, S. Lee and J. S. Park, Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process, Int. J. Pharm. 301 (2005) 199-208; DOI: 10.1016/j.ijpharm.2005.05.017. (Pubitemid 41206604)
12. United States Pharmacopoeia 24/National Formulary 19, USP Convention, Rockville 2000, p. 2235.
13. P. Costa and L. J. Manuel Sousa, Modelling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133; DOI: 10.1016/S0928-0987(01) 00095-1. (Pubitemid 32288781)
14. J. W. Moore and H. H. Flanner, Mathematical comparison of dissolution profiles, Pharm. Tech. 20 (1996) 64-74.
15. R. P. Patel and M. M. Patel, Solid-state characterization and dissolution properties of lovastatin hydroxypropyl-beta-cyclodextrin inclusion complex, Pharm. Tech. 2 (2007) 72-81.
16. S. Baboota, M. Dhalival and K. Kohli, Physicochemical characterization, in vitro dissolution behaviour, and pharmacodynamic studies of rofecoxib-cyclodextrin inclusion compounds: preparation and properties of rofecoxib hydroxypropyl b-cyclodextrin inclusion complex: a technical note, AAPS Pharm. Sci. Tech. 6 (2005) 83-90; DOI: 10.1208/pt060114. (Pubitemid 41630997)
17. M. A. Khan and A. A. Karnachi, Box-Behnken design for the optimization of formulation variables of indomethacin co-precipitates with polymer mixtures, Int. J. Pharm. 131 (1996) 9-17; DOI: 10.1016/0378-5173(95)04216-4. (Pubitemid 26143823)
18. S. Torrado, P. D. Torre and S. Torrado, Preparation, dissolution and characterization of pranziquantel solid dispersions, Chem. Pharm. Bull. 47 (1999) 1629-1633; DOI: 99A1042280.
19. S. R. Vikram, M. R. Shelake, S. S. Shetty, A. B. Chavan-Patil, Y. V. Pore and S. G. Late, Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique, J. Pharm. Pharm. Sci. 60 (2008) 1121-1129; DOI: 10.1211/jpp.60.9.0002.
20. K. Okimoto, M. Miyake, R. Ibuki, M. Yasumura, N. Ohnishi and T. Nakai, Dissolution mechanism and rate of solid dispersion particles of nilvadipine with hydroxypropylmethylcellulose, Int. J. Pharm. 159 (1997) 85-93; DOI: 10.1016/S0378-5173(97)00274-3. (Pubitemid 28062813)
21. M. S. Nagarsenker and M. S. Joshi, Celecoxib cyclodextrin systems: Characterization and evaluation of in vitro and in vivo advantage, Drug Dev. Ind. Pharm. 31 (2005) 169-178; DOI: 10.1081/ DDC-200047795.